120 related articles for article (PubMed ID: 38101574)
1. WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines.
Close DA; Johnston PA
SLAS Discov; 2023 Dec; 29(1F):130. PubMed ID: 38101574
[No Abstract] [Full Text] [Related]
2. Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines.
Close DA; Johnston PA
SLAS Discov; 2022 Jan; 27(1):39-54. PubMed ID: 35058175
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.
Kochanek SJ; Close DA; Camarco DP; Johnston PA
SLAS Discov; 2020 Apr; 25(4):329-349. PubMed ID: 31983262
[TBL] [Abstract][Full Text] [Related]
4. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
5. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures.
Essid N; Chambard JC; Elgaaïed AB
Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.
Kadletz L; Heiduschka G; Domayer J; Schmid R; Enzenhofer E; Thurnher D
Oncol Lett; 2015 Sep; 10(3):1281-1286. PubMed ID: 26622664
[TBL] [Abstract][Full Text] [Related]
7. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer.
Sturgis EM; Sacks PG; Masui H; Mendelsohn J; Schantz SP
Otolaryngol Head Neck Surg; 1994 Nov; 111(5):633-43. PubMed ID: 7970803
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.
Sacks PG; Parnes SM; Gallick GE; Mansouri Z; Lichtner R; Satya-Prakash KL; Pathak S; Parsons DF
Cancer Res; 1988 May; 48(10):2858-66. PubMed ID: 2452013
[TBL] [Abstract][Full Text] [Related]
10. Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival.
Braunholz D; Saki M; Niehr F; Öztürk M; Borràs Puértolas B; Konschak R; Budach V; Tinhofer I
PLoS One; 2016; 11(9):e0163149. PubMed ID: 27643613
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Taxol in head and neck squamous carcinoma multicellular tumor spheroids.
Griffon-Etienne G; Merlin JL; Marchal C
Anticancer Drugs; 1997 Jan; 8(1):48-55. PubMed ID: 9147611
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of Conditions for the Formation of Spheroids of Head and Neck Squamous Cell Carcinoma Cell Lines for Use as Animal Alternatives.
Tenschert E; Kern J; Affolter A; Rotter N; Lammert A
Altern Lab Anim; 2022 Nov; 50(6):414-422. PubMed ID: 36263982
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods.
Li D; Thomas C; Shrivastava N; Gersten A; Gadsden N; Schlecht N; Kawachi N; Schiff BA; Smith RV; Rosenblatt G; Augustine S; Gavathiotis E; Burk R; Prystowsky MB; Guha C; Mehta V; Ow TJ
J Med Virol; 2023 Feb; 95(2):e28388. PubMed ID: 36477880
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model.
Balló H; Koldovsky P; Hoffmann T; Balz V; Hildebrandt B; Gerharz CD; Bier H
Anticancer Res; 1999; 19(5B):3827-36. PubMed ID: 10628319
[TBL] [Abstract][Full Text] [Related]
15. Mapping Cell-in-Cell Structures in Oral Squamous Cell Carcinoma.
Siquara da Rocha LO; Souza BSF; Coletta RD; Lambert DW; Gurgel Rocha CA
Cells; 2023 Oct; 12(19):. PubMed ID: 37830632
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2.
Mortensen ACL; Morin E; Brown CJ; Lane DP; Nestor M
EJNMMI Res; 2020 Apr; 10(1):38. PubMed ID: 32300907
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid metabolite expression by head and neck squamous cell carcinoma.
Mann EA; Spiro JD; Chen LL; Kreutzer DL
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):763-9. PubMed ID: 8018329
[TBL] [Abstract][Full Text] [Related]
18. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA
Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110
[TBL] [Abstract][Full Text] [Related]
20. Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer.
Toustrup K; Sørensen BS; Nordsmark M; Busk M; Wiuf C; Alsner J; Overgaard J
Cancer Res; 2011 Sep; 71(17):5923-31. PubMed ID: 21846821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
